(Q44512551)

3 December 2017

title

Prostate-specific antigen levels in young white and black men 20 to 45 years old. (English)

1 reference

3 December 2017

4

1 reference

3 December 2017

3

Jacobson DJ

1 reference

3 December 2017

Preston DM

1

1 reference

3 December 2017

Levin LI

2

1 reference

3 December 2017

Rubertone M

5

1 reference

3 December 2017

Holmes E

6

1 reference

3 December 2017

Murphy GP

7

1 reference

3 December 2017

Moul JW

8

1 reference

3 December 2017

language of work or name

English

0 references

publication date

1 November 2000

1 reference

3 December 2017

1 reference

3 December 2017

volume

56

1 reference

3 December 2017

issue

5

1 reference

3 December 2017

page(s)

812-816

1 reference

Using prostate-specific antigen to diagnose prostate cancer: sailing in uncharted waters

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900764-0

7 January 2021

Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900764-0

7 January 2021

Prostate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900764-0

7 January 2021

The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900764-0

7 January 2021

Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900764-0

7 January 2021

Reference ranges for serum prostate-specific antigen in black and white men without cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900764-0

7 January 2021

Age-specific reference ranges for serum prostate-specific antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900764-0

7 January 2021

Age- and race-specific reference ranges for prostate-specific antigen from a large community-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900764-0

7 January 2021

Age-specific reference ranges for serum prostate-specific antigen in black men.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900764-0

7 January 2021

The influence of ejaculation on serum levels of prostate specific antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900764-0

7 January 2021

Defining and updating the American Cancer Society guidelines for the cancer-related checkup: prostate and endometrial cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900764-0

7 January 2021

The U.S. Army HIV testing program: the first decade.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900764-0

7 January 2021

Comparison of serum prostate-specific antigen levels and PSA density in African-American, white, and Hispanic men without prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900764-0

7 January 2021

Influence of age and prostate-specific antigen on the chance of curable prostate cancer among men with nonpalpable disease

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900764-0

7 January 2021

Stability of serum prostate-specific antigen determination across laboratory, assay, and storage time

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900764-0

7 January 2021

10.1016/S0090-4295(00)00764-0

Identifiers

DOI

1 reference

3 December 2017

1 reference